Criterion | sPESI |
---|---|
Age > 80 years | 1 |
Malignancy | 1 |
Heart failure or lung disease | 1 |
Heart rate ≥ 110/min | 1 |
Systolic blood pressure < 100 mmHg | 1 |
Oxygen saturation < 90% with indoor air | 1 |
Interpretation | |
sPESI score | 30-day risk of death |
0 points | 1.1% |
1 point or more | 8.9% |
1 Source: Jiménez D, Aujesky D, Moores L et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170(15):1383-9 [PubMed]. | ||||||||||||||||||||||||
Predisposing factors
Symptoms and findings
Clinical assessmentAssessment of pretest probability
Assessment of the clinical pretest probability of pulmonary embolism1 . Source: Finnish Current Care Guideline on deep vein thrombosis and pulmonary embolism 2023 1.
| ||||||||||||||||||||||||
1 Source: Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-420 [PubMed] | ||||||||||||||||||||||||
Investigation and treatment strategy in suspected PE D-Dimer Testing and Pulmonary Embolism
Diagnosing PE Safety of Ruling out Acute Pulmonary Embolism in Outpatients by Normal Computed Tomography Pulmonary AngiographyLaboratory testsD-dimer
Other laboratory tests
Arterial blood gas analysis
ECG
CT angiography of the pulmonary arteries
Ultrasonography of the lower extremities
Perfusion scan (nuclear scan)
Treatment Outpatient Treatment for Acute Pulmonary EmbolismTreatment of circulatory shock
Choice of treatment
Anticoagulant therapy Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Thrombolytic therapy (fibrinolytic therapy) Thrombolytic Therapy in Pulmonary Embolism
Invasive catheter treatment or surgical management
Inferior vena cava filter (IVC filter) Vena Caval Filters for the Prevention of Pulmonary Embolism
Discharge and further treatment
References
|